AU2012308240A1 - Immunotherapy and diagnosis of mucormycosis using CotH - Google Patents

Immunotherapy and diagnosis of mucormycosis using CotH Download PDF

Info

Publication number
AU2012308240A1
AU2012308240A1 AU2012308240A AU2012308240A AU2012308240A1 AU 2012308240 A1 AU2012308240 A1 AU 2012308240A1 AU 2012308240 A AU2012308240 A AU 2012308240A AU 2012308240 A AU2012308240 A AU 2012308240A AU 2012308240 A1 AU2012308240 A1 AU 2012308240A1
Authority
AU
Australia
Prior art keywords
nucleic acid
polypeptide
seq
coth
mucorales
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2012308240A
Other languages
English (en)
Inventor
John E. Edwards
Scott Filler
Yue Fu
Teklegiorgis GHEBREMARIAM
Ashraf S. Ibrahim
Mingfu Liu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center
Original Assignee
Los Angeles Biomedical Research Institute at Harbor-Ucla Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Los Angeles Biomedical Research Institute at Harbor-Ucla Medical Center filed Critical Los Angeles Biomedical Research Institute at Harbor-Ucla Medical Center
Publication of AU2012308240A1 publication Critical patent/AU2012308240A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/14—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from fungi, algea or lichens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56961—Plant cells or fungi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/37—Assays involving biological materials from specific organisms or of a specific nature from fungi
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/10—Detection of antigens from microorganism in sample from host

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2012308240A 2011-09-15 2012-09-14 Immunotherapy and diagnosis of mucormycosis using CotH Abandoned AU2012308240A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161535257P 2011-09-15 2011-09-15
US61/535,257 2011-09-15
PCT/US2012/055659 WO2013040517A2 (en) 2011-09-15 2012-09-14 IMMUNOTHERAPY AND DIAGNOSIS OF MUCORMYCOSIS USING CotH

Publications (1)

Publication Number Publication Date
AU2012308240A1 true AU2012308240A1 (en) 2013-05-02

Family

ID=47884011

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2012308240A Abandoned AU2012308240A1 (en) 2011-09-15 2012-09-14 Immunotherapy and diagnosis of mucormycosis using CotH

Country Status (7)

Country Link
US (3) US9279002B2 (enExample)
EP (1) EP2755681B1 (enExample)
JP (1) JP2014528715A (enExample)
CN (1) CN103998057A (enExample)
AU (1) AU2012308240A1 (enExample)
CA (1) CA2848765A1 (enExample)
WO (1) WO2013040517A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10465233B2 (en) 2016-03-25 2019-11-05 The Government Of The United States Of America, As Represented By The Secretary Of The Navy Time-resolved nucleic acid hybridization beacons
US10960002B2 (en) 2016-05-13 2021-03-30 The Brigham And Women's Hospital, Inc. Volatile metabolite profiles for the diagnosis and treatment of Mucorales fungi
WO2018094322A1 (en) * 2016-11-21 2018-05-24 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Novel fungal toxins and methods related to the same
EP4334344A4 (en) * 2021-05-06 2025-07-02 Lundquist Inst For Biomedical Innovation At Harbor Ucla Medical Center COTH3 BINDING AGENTS AND THEIR USES
CN114324896A (zh) * 2021-12-31 2022-04-12 菲鹏生物股份有限公司 特异性结合mucoricin蛋白的试剂的用途和毛霉菌检测试剂盒
CN114568490B (zh) * 2022-04-01 2023-12-19 眉山职业技术学院(眉山技师学院) 雷帕霉素在抑制柑橘青霉菌生长中的应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405712A (en) 1981-07-01 1983-09-20 The United States Of America As Represented By The Department Of Health And Human Services LTR-Vectors
US4650764A (en) 1983-04-12 1987-03-17 Wisconsin Alumni Research Foundation Helper cell
US4493795A (en) 1983-10-17 1985-01-15 Syntex (U.S.A.) Inc. Synthetic peptide sequences useful in biological and pharmaceutical applications and methods of manufacture
US4897355A (en) 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
JP2561478B2 (ja) 1986-07-22 1996-12-11 武田薬品工業株式会社 グリセリン誘導体
JP2914692B2 (ja) 1987-12-11 1999-07-05 ホワイトヘツド・インスチチユート・フオー・バイオメデイカル・リサーチ 内皮細胞の遺伝子修飾
WO1990006997A1 (en) 1988-12-13 1990-06-28 United States Government As Represented By The Secretary Of The Department Of Health And Human Services Genetically engineered endothelial cells and use thereof
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5399346A (en) 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
US5283173A (en) 1990-01-24 1994-02-01 The Research Foundation Of State University Of New York System to detect protein-protein interactions
US5877397A (en) 1990-08-29 1999-03-02 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
AU665176B2 (en) 1990-09-21 1995-12-21 Novartis Vaccines And Diagnostics, Inc. Packaging cells
DE69128893T2 (de) 1990-10-31 1998-09-10 Brigham & Womens Hospital Genetische veränderung von endothelzellen
WO1992014829A1 (en) 1991-02-19 1992-09-03 The Regents Of The University Of California Viral particles having altered host range
US5252479A (en) 1991-11-08 1993-10-12 Research Corporation Technologies, Inc. Safe vector for gene therapy
US5334761A (en) 1992-08-28 1994-08-02 Life Technologies, Inc. Cationic lipids
WO2003018051A1 (en) * 2001-08-27 2003-03-06 Vic Jira Anti-fungal composition
GB0205378D0 (en) * 2002-03-07 2002-04-24 Royal Holloway University Of L Bacterial spores
EP2049669A2 (en) * 2006-08-09 2009-04-22 DSMIP Assets B.V. Spore surface displays of bioactive molecules
WO2009108652A1 (en) * 2008-02-28 2009-09-03 3M Innovative Properties Company Antibodies to clostridium difficile spores and uses thereof
CA2755273A1 (en) * 2009-03-19 2010-09-23 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Vaccine compositions and methods for treatment of mucormycosis and other fungal diseases
US20110059111A1 (en) * 2009-09-01 2011-03-10 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Mammalian receptors as targets for antibody and active vaccination therapy against mold infections

Also Published As

Publication number Publication date
US9279002B2 (en) 2016-03-08
EP2755681A4 (en) 2015-05-13
WO2013040517A2 (en) 2013-03-21
US20190194301A1 (en) 2019-06-27
US20160159887A1 (en) 2016-06-09
CA2848765A1 (en) 2013-03-21
CN103998057A (zh) 2014-08-20
WO2013040517A3 (en) 2013-07-18
EP2755681A2 (en) 2014-07-23
JP2014528715A (ja) 2014-10-30
EP2755681B1 (en) 2018-06-27
US20130108642A1 (en) 2013-05-02

Similar Documents

Publication Publication Date Title
US20190194301A1 (en) Immunotherapy and diagnosis of mucormycosis using coth
EP1187850A1 (en) Antimicrobial theta defensins and methods of using same
JP2002508668A (ja) 疾病の処置及び診断に有用なｔｎｆファミリーのメンバー
EP1636269A2 (en) Extracellular aspergillus polypeptides
US20120014995A1 (en) Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents
US7927832B2 (en) Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto
CN106279423B (zh) Slit2D2-HSA融合蛋白及其在抗肿瘤中的应用
JP2002505882A (ja) キチナーゼのキチン結合性断片
US20160130330A1 (en) Mammalian receptors as targets for antibody and active vaccination therapy against mold infections
AU2010236145A1 (en) New methods of making an antibody and compositions thereof
US7067138B1 (en) Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis
US20060241288A1 (en) Extracellular aspergillus polypeptides
US20020034751A1 (en) Aspergillus fumigatus antigenic protein 1
WO2003018629A1 (en) Cage antigen
EP2094279B1 (en) Methods and compositions for treating influenza
US6020164A (en) Human RNA binding proteins
US6638734B1 (en) Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto
JP2008540453A (ja) 播種性カンジダ症および他の感染性因子に対してワクチン接種するための薬学的組成物および方法
US20030092083A1 (en) Cage antigen
CN1948335B (zh) 白念珠菌菌丝调控因子基因及其用途
JPWO2013024517A1 (ja) アスペルギルスフミガーツス感染症の検査、予防及び治療のための方法並びに組成物
WO2005071070A2 (en) Substances directed against specific sequence essential for heparanase catalytic activity end uses thereof as heparanase inhibitors
WO2000077207A2 (en) Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto
CN106699892B (zh) 肺鳞癌中dnah5融合基因及其用途
CN120795160A (zh) 抗猪caspase-7的单克隆抗体及其应用

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted